Sinopharm Group Statistics
Total Valuation
Sinopharm Group has a market cap or net worth of 7.01 billion. The enterprise value is 16.16 billion.
| Market Cap | 7.01B |
| Enterprise Value | 16.16B |
Important Dates
The last earnings date was Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | Jun 17, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.34B |
Valuation Ratios
The trailing PE ratio is 7.26.
| PE Ratio | 7.26 |
| Forward PE | n/a |
| PS Ratio | 0.09 |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.73 |
| P/FCF Ratio | 5.08 |
| P/OCF Ratio | 4.43 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.00, with an EV/FCF ratio of 11.71.
| EV / Earnings | 16.73 |
| EV / Sales | 0.20 |
| EV / EBITDA | 5.00 |
| EV / EBIT | 6.19 |
| EV / FCF | 11.71 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.60.
| Current Ratio | 1.39 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 3.42 |
| Debt / FCF | 7.58 |
| Interest Coverage | 6.54 |
Financial Efficiency
Return on equity (ROE) is 8.44% and return on invested capital (ROIC) is 5.61%.
| Return on Equity (ROE) | 8.44% |
| Return on Assets (ROA) | 2.87% |
| Return on Invested Capital (ROIC) | 5.61% |
| Return on Capital Employed (ROCE) | 12.51% |
| Revenue Per Employee | 739,990 |
| Profits Per Employee | 8,925 |
| Employee Count | 108,217 |
| Asset Turnover | 1.51 |
| Inventory Turnover | 8.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.62% in the last 52 weeks. The beta is 0.63, so Sinopharm Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -17.62% |
| 50-Day Moving Average | 2.58 |
| 200-Day Moving Average | 2.63 |
| Relative Strength Index (RSI) | 45.42 |
| Average Volume (20 Days) | 1,119 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sinopharm Group had revenue of 80.08 billion and earned 965.83 million in profits. Earnings per share was 0.31.
| Revenue | 80.08B |
| Gross Profit | 6.06B |
| Operating Income | 2.44B |
| Pretax Income | 1.92B |
| Net Income | 965.83M |
| EBITDA | 2.74B |
| EBIT | 2.44B |
| Earnings Per Share (EPS) | 0.31 |
Balance Sheet
The company has 7.88 billion in cash and 10.47 billion in debt, giving a net cash position of -2.59 billion.
| Cash & Cash Equivalents | 7.88B |
| Total Debt | 10.47B |
| Net Cash | -2.59B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 17.36B |
| Book Value Per Share | 3.46 |
| Working Capital | 13.30B |
Cash Flow
In the last 12 months, operating cash flow was 1.58 billion and capital expenditures -201.60 million, giving a free cash flow of 1.38 billion.
| Operating Cash Flow | 1.58B |
| Capital Expenditures | -201.60M |
| Free Cash Flow | 1.38B |
| FCF Per Share | n/a |
Margins
Gross margin is 7.57%, with operating and profit margins of 3.05% and 1.21%.
| Gross Margin | 7.57% |
| Operating Margin | 3.05% |
| Pretax Margin | 2.40% |
| Profit Margin | 1.21% |
| EBITDA Margin | 3.42% |
| EBIT Margin | 3.05% |
| FCF Margin | 1.72% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 5.69%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 5.69% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 38.51% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.69% |
| Earnings Yield | 13.78% |
| FCF Yield | 19.69% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sinopharm Group has an Altman Z-Score of 2.26. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.26 |
| Piotroski F-Score | n/a |